China Health Industries Holdings, Inc.
CHHE
$0.00
$0.000.00%
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 77.26% | 258.41% | -- | 37,100.00% | -87.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 77.26% | 258.41% | -- | 37,100.00% | -87.49% |
| Cost of Revenue | 107.39% | 305.41% | -- | 6,447.06% | -84.49% |
| Gross Profit | -196.23% | -193.33% | -- | 113.33% | -95.52% |
| SG&A Expenses | -5.41% | 2.92% | 2.48% | 37.47% | 51.08% |
| Depreciation & Amortization | -60.37% | -44.74% | -27.81% | -21.63% | 2.36% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.65% | -10.09% | -0.96% | 18.57% | 8.13% |
| Operating Income | 25.56% | 14.85% | 9.76% | -11.82% | -39.14% |
| Income Before Tax | -293.10% | -310.60% | 84.92% | -16.44% | 162.60% |
| Income Tax Expenses | -- | -- | -- | -- | -78.52% |
| Earnings from Continuing Operations | -293.89% | -311.46% | 82.93% | -15.48% | 161.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -293.89% | -311.46% | 82.93% | -15.48% | 161.60% |
| EBIT | 25.56% | 14.85% | 9.76% | -11.82% | -39.14% |
| EBITDA | 13.14% | -2.84% | 1.64% | -41.43% | -82.36% |
| EPS Basic | -294.39% | -312.96% | 83.61% | -12.73% | 161.14% |
| Normalized Basic EPS | -292.54% | -310.29% | 86.05% | -14.71% | 162.04% |
| EPS Diluted | -294.39% | -312.96% | 83.61% | -12.73% | 161.14% |
| Normalized Diluted EPS | -292.54% | -310.29% | 86.05% | -14.71% | 162.04% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |